Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield

Adar Poonawalla further said Serum Institute of India (SII) will make 6-7 million doses of Covishield available in 90 days and it could take up to nine months to further build up the stock based on demand.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zaRP0gD
via IFTTT

0 comments:

Post a Comment